Showing results (1961-1970 of 2,023) with videos related to
Sort By:
Pageof 203
American Journal of Respiratory and Critical Care Medicine|September 6, 2017
Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung TransplantEdward Cantu, Joshua M Diamond, Yoshikazu Suzuki, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 29, 2022
Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort studyElizabeth N Pavlisko, Megan L Neely, Heather Kopetskie, et al.BMJ Open|July 5, 2022
Acute pain pathways: protocol for a prospective cohort studyMolly Moore Jeffery, Mitra Ahadpour, Summer Allen, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2015
Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction RiskE Cantu, Y Suzuki, J M Diamond, et al.Kidney International Supplements|March 10, 2020
Considerations on equity in management of end-stage kidney disease in low- and middle-income countriesWim Van Biesen, Vivekanand Jha, Ali K Abu-Alfa, et al.JCI Insight|January 26, 2018
Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injuryCiara M Shaver, Nancy Wickersham, J Brennan McNeil, et al.Pediatric Dermatology|April 17, 2020
Management of infantile hemangiomas during the COVID pandemicIlona J Frieden, Katherine B Püttgen, Beth A Drolet, et al.BMC Cardiovascular Disorders|July 5, 2024
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record dataFardad Soltani, David A Jenkins, Amit Kaura, et al.Journal for Immunotherapy of Cancer|August 30, 2023
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3Bijal D Shah, Ryan D Cassaday, Jae H Park, et al.BMC Medical Informatics and Decision Making|October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisionsAlvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.Pageof 203